Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nageatte Ibrahim

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Annual Review of Pathology|April 30, 2009
Molecular pathogenesis of cutaneous melanocytic neoplasmsNageatte Ibrahim, Frank G Haluska
Current Oncology Reports|August 12, 2006
Therapeutic targets in melanoma: map kinase pathwayFrank G Haluska, Nageatte Ibrahim
Seminars in Oncology|December 18, 2007
The RTK/RAS/BRAF/PI3K pathways in melanoma: biology, small molecule inhibitors, and potential applicationsFrank Haluska, Trevor Pemberton, Nageatte Ibrahim, et al.
Investigational New Drugs|February 15, 2013
Ipilimumab associated hepatitis: imaging and clinicopathologic findingsKyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, et al.
AJR. American Journal of Roentgenology|May 31, 2013
Ipilimumab-associated colitis: CT findingsKyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, et al.
Journal for Immunotherapy of Cancer|February 10, 2019
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?Meihua Wang, Cong Chen, Thomas Jemielita, et al.
Oncotarget|December 31, 2016
Vitamin D deficiency is associated with a worse prognosis in metastatic melanomaDmitriy Timerman, Melissa McEnery-Stonelake, Cara J Joyce, et al.
Cancer Research|September 3, 2010
BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinomaNageatte Ibrahim, Lei He, Chee-Onn Leong, et al.
Journal of Cutaneous Pathology|June 3, 2016
Distinct genetic profiles of extracranial and intracranial acral melanoma metastasesGaurav Sharma, Christine G Lian, William M Lin, et al.
Cancer Medicine|October 18, 2016
A phase I trial of panobinostat (LBH589) in patients with metastatic melanomaNageatte Ibrahim, Elizabeth I Buchbinder, Scott R Granter, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Annual Review of Pathology|April 30, 2009
Molecular pathogenesis of cutaneous melanocytic neoplasmsNageatte Ibrahim, Frank G Haluska
Current Oncology Reports|August 12, 2006
Therapeutic targets in melanoma: map kinase pathwayFrank G Haluska, Nageatte Ibrahim
Seminars in Oncology|December 18, 2007
The RTK/RAS/BRAF/PI3K pathways in melanoma: biology, small molecule inhibitors, and potential applicationsFrank Haluska, Trevor Pemberton, Nageatte Ibrahim, et al.
Investigational New Drugs|February 15, 2013
Ipilimumab associated hepatitis: imaging and clinicopathologic findingsKyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, et al.
AJR. American Journal of Roentgenology|May 31, 2013
Ipilimumab-associated colitis: CT findingsKyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, et al.
Journal for Immunotherapy of Cancer|February 10, 2019
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?Meihua Wang, Cong Chen, Thomas Jemielita, et al.
Oncotarget|December 31, 2016
Vitamin D deficiency is associated with a worse prognosis in metastatic melanomaDmitriy Timerman, Melissa McEnery-Stonelake, Cara J Joyce, et al.
Cancer Research|September 3, 2010
BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinomaNageatte Ibrahim, Lei He, Chee-Onn Leong, et al.
Journal of Cutaneous Pathology|June 3, 2016
Distinct genetic profiles of extracranial and intracranial acral melanoma metastasesGaurav Sharma, Christine G Lian, William M Lin, et al.
Cancer Medicine|October 18, 2016
A phase I trial of panobinostat (LBH589) in patients with metastatic melanomaNageatte Ibrahim, Elizabeth I Buchbinder, Scott R Granter, et al.
Pageof 6